Steven A. Curley

Steven A. Curley

Auto-generated profile, based on publicly available information

Steven A. Curley

Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2016 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
MWMatthew James Ware
Matthew James Ware
KCKevin Colbert
Kevin Colbert
VKVazrik Keshishian
Vazrik Keshishian
JHJason Chak-Shing Ho
Jason Chak-Shing Ho
SCStuart James Corr
Stuart James Corr
Biana GodinBiana Godin
Biana Godin
In vitro characterization of tumor cell biology or of potential anticancer drugs is usually performed using tumor cell lines cultured as a monolayer. However, it has been previously shown that three-dimensional (3D) organization of the tumor cells is important to provide insights on tumor biology and transport of therapeutics. Several methods to create 3D tumors in vitro have been proposed, with hanging drop technique being the most simple and, thus, most frequently used. However, in many cell lines this method has failed to form the desired 3D tumor structures. The aim of this study was to design and test an easy-to-use and highly reproducible modification of the hanging drop method for tumor sphere formation by adding methylcellulose polymer. Most pancreatic cancer cells do not form cohesive and manageable spheres when the original hanging drop method is used, thus we investigated these cell lines for our modified hanging drop method. The spheroids produced by this improved technique were analyzed by histology, light microscopy, immunohistochemistry, and scanning electron microscopy. Results show that using the proposed simple method; we were able to produce uniform spheroids for all five of the tested human pancreatic cancer cell lines; Panc-1, BxPC-3, Capan-1, MiaPaCa-2, and AsPC-1. We believe that this method can be used as a reliable and reproducible technique to make 3D cancer spheroids for use in tumor biology research and evaluation of therapeutic responses, and for the development of bio-artificial tissues.

25 August 2017 in Cancer
Verified
Journal Article
Closed access
PDF file
HCHop S Tran Cao
Hop S Tran Cao
QZQianzi Zhang
Qianzi Zhang
YSYvonne H. Sada
Yvonne H. Sada
CCChristy Chai
Christy Chai
SCSteven A. Curley
Steven A. Curley
NMNader N. Massarweh
Nader N. Massarweh

18 October 2012 in The Journal of Physical Chemistry C
Verified
Journal Article
Open access
SCStuart J. Corr
Stuart J. Corr
MRMustafa Raoof
Mustafa Raoof
YMYuri Mackeyev
Yuri Mackeyev
SPSophia Phounsavath
Sophia Phounsavath
MCMatthew Cheney
Matthew Cheney
SCSteven A. Curley
Steven A. Curley
The evaluation of heat production from gold nanoparticles (AuNPs) irradiated with radio-frequency (RF) energy has been problematic due to Joule heating of their background ionic buffer suspensions. Insights into the physical heating mechanism of nanomaterials under RF excitations must be obtained if they are to have applications in fields such as nanoparticle-targeted hyperthermia for cancer therapy. By developing a purification protocol that allows for highly stable and concentrated solutions of citrate-capped AuNPs to be suspended in high-resistivity water, we show herein, for the first time, that heat production is only evident for AuNPs of diameters ≤10 nm, indicating a unique size-dependent heating behavior not previously observed. Heat production has also shown to be linearly dependent on both AuNP concentration and total surface area and was severely attenuated upon AuNP aggregation. These relationships have been further validated using permittivity analysis across a frequency range of 10 MHz–3 GHz as well as static conductivity measurements. Theoretical evaluations suggest that the heating mechanism can be modeled by the electrophoretic oscillation of charged AuNPs across finite length scales in response to a time-varying electric field. It is anticipated these results will assist future development of nanoparticle-assisted heat production by RF fields for applications such as targeted cancer hyperthermia.

1 August 2014 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
MRMustafa Raoof
Mustafa Raoof
SCStuart J. Corr
Stuart J. Corr
CZCihui Zhu
Cihui Zhu
BCBrandon T. Cisneros
Brandon T. Cisneros
WKWarna D. Kaluarachchi
Warna D. Kaluarachchi
SCSteven A. Curley
Steven A. Curley

SCSteven A. Curley
Steven A. Curley
FPFlavio Palalon
Flavio Palalon
KSKelly E. Sanders
Kelly E. Sanders
NKNadya Koshkina
Nadya Koshkina
Background: Exposure of biological subjects to electromagnetic fields with a high frequency is associated with temperature elevation. In our recent studies, we reported that non-invasive radiofrequency (RF) treatment at 13.56 MHz with the field ranging from 1 KeV to 20 KeV/m2 inhibits tumor progression in animals with abdominal tumor xenografts and enhances the anticancer effect of chemotherapy. The RF treatment was followed by temperature elevation in tumors to approximately 46 °C during 10 min of exposure. In contrast, the temperature of normal tissues remained within a normal range at approximately 37 °C. Whether all biological effects of RF treatment are limited to its hyperthermic property remains unclear. Here, we compared how RF and hyperthermia (HT) treatments change the proliferation rate, oxygen consumption and autophagy in malignant and nonmalignant cells. Methods: In the current study, cancer and nonmalignant cells of pancreatic origin were exposed to the RF field or to conventional HT at 46 °C, which was chosen based on our previous in vivo studies of the tumor-specific RF-induced hyperthermia. Results: Only RF treatment caused declines in cancer cell viability and proliferation. RF treatment also affected mitochondrial function in cancer cells more than HT treatment did and, unlike HT treatment, was followed by the elevation of autophagosomes in the cytoplasm of cancer cells. Importantly, the effects of RF treatment were negligible in nonmalignant cells. Conclusion: The obtained data indicate that the effects of RF treatment are specific to cancer cells and are not limited to its hyperthermic property.

15 August 2014 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
MRMustafa Raoof
Mustafa Raoof
CZCihui Zhu
Cihui Zhu
BCBrandon T. Cisneros
Brandon T. Cisneros
HLHeping Liu
Heping Liu
SCStuart J. Corr
Stuart J. Corr
SCSteven A. Curley
Steven A. Curley
Gemcitabine is a potent nucleoside analogue against solid tumors, but development of drug resistance is a substantial problem. Removal of gemcitabine incorporated into DNA by repair mechanisms may contribute to resistance in chemo-refractory solid tumors. Human hepatocellular carcinoma (HCC) is usually very chemoresistant to gemcitabine. We treated HCC in vitro and in vivo (orthotopic murine model with human Hep3B or HepG2 xenografts, 7–10 CB17SCID mice per group) with gemcitabine. The role of homologous recombination repair proteins in repairing stalled replication forks was evaluated with hyperthermia exposure and cell-cycle analysis. The Student t-test was used for two-sample comparisons. Multiple group data were analyzed using one-way analysis of variance. All statistical tests were two-sided. We demonstrated that Mre11-mediated homologous recombination repair of gemcitabine-stalled replication forks is crucial to survival of HCC cells. Furthermore, we demonstrated inhibition of Mre11 by an exonuclease inhibitor or concomitant hyperthermia. In orthotopic murine models of chemoresistant HCC, the Hep3B tumor mass with radiofrequency plus gemcitabine treatment (mean ± SD, 180±91mg) was statistically significantly smaller compared with gemcitabine alone (661±419mg, P = .0063). This study provides mechanistic understanding of homologous recombination inhibiting-strategies, such as noninvasive radiofrequency field-induced hyperthermia, to overcome resistance to gemcitabine in refractory human solid tumors.